NYSE:CC Chemours - CC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. $35.89 -0.08 (-0.22%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$35.34▼$36.1950-Day Range$29.54▼$36.3952-Week Range$22.56▼$44.95Volume829,348 shsAverage Volume820,441 shsMarket Capitalization$5.42 billionP/E Ratio6.40Dividend Yield2.75%Price Target$34.10 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Chemours MarketRank™ ForecastAnalyst RatingHold2.18 Rating ScoreUpside/Downside5.0% Downside$34.10 Price TargetShort InterestHealthy2.60% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews Sentiment0.26Based on 10 Articles This WeekInsider TradingN/AProj. Earnings Growth-7.07%From $4.67 to $4.34 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.20 out of 5 starsBasic Materials Sector73rd out of 159 stocksChemicals & Allied Products Industry6th out of 15 stocks 1.1 Analyst's Opinion Consensus RatingChemours has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $34.10, Chemours has a forecasted downside of 5.0% from its current price of $35.89.Amount of Analyst CoverageChemours has only been the subject of 4 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.60% of the float of Chemours has been sold short.Short Interest Ratio / Days to CoverChemours has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemours has recently decreased by 6.99%, indicating that investor sentiment is improving significantly. Previous Next 2.5 Dividend Strength Dividend YieldChemours pays a meaningful dividend of 2.75%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthChemours does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Chemours is 17.83%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemours will have a dividend payout ratio of 23.04% next year. This indicates that Chemours will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CC. Previous Next 2.4 News and Social Media Coverage News SentimentChemours has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Chemours this week, compared to 5 articles on an average week.Search InterestOnly 3 people have searched for CC on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows14 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is an increase of 367% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemours insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.04% of the stock of Chemours is held by insiders.Percentage Held by Institutions71.89% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Chemours are expected to decrease by -7.07% in the coming year, from $4.67 to $4.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemours is 6.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 137.84.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemours is 6.40, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 100.43.Price to Earnings Growth RatioChemours has a PEG Ratio of 0.75. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioChemours has a P/B Ratio of 5.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Chemours (NYSE:CC) StockThe Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.Read More Receive CC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter. Email Address CC Stock News HeadlinesJanuary 29, 2023 | marketbeat.comThese 2 “Buy Signals” Delivered Safe 7%+ Payouts, 90% ReturnsFebruary 3, 2023 | americanbankingnews.comThe Chemours Company (NYSE:CC) Receives Average Rating of "Hold" from BrokeragesFebruary 4, 2023 | Wall Street Watch Dogs (Ad)“Future Fuel” will unleash $11 trillion wave of wealthThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…February 1, 2023 | finance.yahoo.comChemours and EastSide Charter School Break Ground on the New Chemours STEM HubFebruary 1, 2023 | americanbankingnews.comShort Interest in The Chemours Company (NYSE:CC) Declines By 7.0%January 31, 2023 | finance.yahoo.comChemours' Minjin Kim Named One of Engineered Systems "20 to Watch: Women in HVAC"January 31, 2023 | finance.yahoo.comChemours Now Taking Orders in North America for Opteon™ XL41 Zero ODP, Low GWP RefrigerantJanuary 26, 2023 | finance.yahoo.comChemours Introduces New Ti-Pure™ Sustainability Grade Enabling Lower Carbon Footprint for Plastics Masterbatch ProducersFebruary 4, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...January 26, 2023 | americanbankingnews.comChemours (NYSE:CC) Sees Large Volume IncreaseJanuary 26, 2023 | americanbankingnews.comChemours (NYSE:CC) Raised to "Buy" at UBS GroupJanuary 24, 2023 | finance.yahoo.comChemours in Europe: Helping to Build a More Sustainable FutureJanuary 22, 2023 | finance.yahoo.comWith 75% ownership of the shares, The Chemours Company (NYSE:CC) is heavily dominated by institutional ownersJanuary 18, 2023 | finance.yahoo.comChemours Announces Dates for Fourth Quarter 2022 Earnings Release and Webcast Conference CallJanuary 17, 2023 | finance.yahoo.comChemours Unveils Ti-Pure(TM) Sustainability (TS) Product Series, Designed to Advance Company & Customers’ Sustainability Goals Through TiO2 InnovationJanuary 12, 2023 | finance.yahoo.comChemours Expands Nafion(TM) Ion Exchange Material Production in France To Support Growing Market Demand for Clean Hydrogen GenerationJanuary 11, 2023 | finance.yahoo.comChemours Expands Nafion™ Ion Exchange Material Production in France to Support Growing Market Demand for Clean Hydrogen GenerationDecember 28, 2022 | finance.yahoo.comChemours director resigns over 'woke culture'December 27, 2022 | marketwatch.com: Citing ‘woke culture,’ Chemours director resigns over abortion benefits for employeesDecember 27, 2022 | finance.yahoo.comCiting ‘woke culture,’ Chemours director resigns over abortion benefits for employeesDecember 13, 2022 | finance.yahoo.comChemours: F-Gas Solutions Are Critical to Achieving Our Biggest Environmental GoalsDecember 12, 2022 | finance.yahoo.comHere's Why We Think Chemours (NYSE:CC) Is Well Worth WatchingDecember 6, 2022 | finance.yahoo.comChemours Unveils Ti-Pure™ Sustainability (TS) Product Series, Designed to Advance Company & Customers’ Sustainability Goals Through TiO2 InnovationDecember 2, 2022 | finance.yahoo.comAlbemarle (ALB) Up 0.3% Since Last Earnings Report: Can It Continue?December 2, 2022 | finance.yahoo.comThis Industrial Stock Looks Dirt Cheap. Is It a Buy?November 30, 2022 | finance.yahoo.comChemours: Chemistry That Connects a Crucial Link in the Domestic Semiconductor Supply ChainNovember 29, 2022 | cnbc.comStocks making the biggest moves in the premarket: Hibbett, Silvergate Capital, Chemours and moreSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter. Email Address CC Company Calendar Last Earnings11/04/2021Ex-Dividend for 12/15 Dividend11/14/2022Dividend Payable12/15/2022Today2/03/2023Next Earnings (Confirmed)2/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:CC CUSIPN/A CIK1627223 Webwww.chemours.com Phone(302) 773-1000FaxN/AEmployees6,400Year FoundedN/APrice Target and Rating Average Stock Price Forecast$34.10 High Stock Price Forecast$43.00 Low Stock Price Forecast$24.00 Forecasted Upside/Downside-5.0%Consensus RatingHold Rating Score (0-4)2.18 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$5.61 Trailing P/E Ratio6.40 Forward P/E Ratio7.69 P/E Growth0.75Net Income$608 million Net Margins12.91% Pretax Margin15.79% Return on Equity73.45% Return on Assets11.42% Debt Debt-to-Equity Ratio2.73 Current Ratio1.82 Quick Ratio1.14 Sales & Book Value Annual Sales$6.35 billion Price / Sales0.85 Cash Flow$6.06 per share Price / Cash Flow5.92 Book Value$6.64 per share Price / Book5.41Miscellaneous Outstanding Shares150,920,000Free Float146,330,000Market Cap$5.42 billion OptionableOptionable Beta1.88 Key ExecutivesMark E. NewmanPresident, Chief Executive Officer & DirectorSameer RalhanChief Financial Officer & Senior Vice PresidentKristine WellmanSecretary, Senior Vice President & General CounselCamela T. WiselChief Accounting Officer, VP & ControllerAlisha BellezzaPresident-Thermal & Specialized SolutionsKey CompetitorsUnivar SolutionsNYSE:UNVRAshlandNYSE:ASHHuntsmanNYSE:HUNLiventNYSE:LTHMBalchemNASDAQ:BCPCView All CompetitorsInsiders & InstitutionsPrivate Management Group Inc.Sold 6,953 shares on 2/3/2023Ownership: 0.337%Hancock Whitney CorpSold 43,345 shares on 2/3/2023Ownership: 0.191%Fisher Asset Management LLCBought 179,115 shares on 2/3/2023Ownership: 0.119%D.A. Davidson & CO.Bought 14,128 shares on 2/3/2023Ownership: 0.009%ProShare Advisors LLCBought 492 shares on 2/2/2023Ownership: 0.011%View All Insider TransactionsView All Institutional Transactions CC Stock - Frequently Asked Questions Should I buy or sell Chemours stock right now? 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares. View CC analyst ratings or view top-rated stocks. What is Chemours' stock price forecast for 2023? 11 brokers have issued 12 month price targets for Chemours' shares. Their CC share price forecasts range from $24.00 to $43.00. On average, they predict the company's stock price to reach $34.10 in the next year. This suggests that the stock has a possible downside of 5.0%. View analysts price targets for CC or view top-rated stocks among Wall Street analysts. How have CC shares performed in 2023? Chemours' stock was trading at $30.62 at the start of the year. Since then, CC stock has increased by 17.2% and is now trading at $35.89. View the best growth stocks for 2023 here. Are investors shorting Chemours? Chemours saw a decline in short interest in January. As of January 15th, there was short interest totaling 3,860,000 shares, a decline of 7.0% from the December 31st total of 4,150,000 shares. Based on an average daily trading volume, of 1,190,000 shares, the short-interest ratio is currently 3.2 days. Currently, 2.6% of the shares of the company are sold short. View Chemours' Short Interest. When is Chemours' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023. View our CC earnings forecast. How can I listen to Chemours' earnings call? Chemours will be holding an earnings conference call on Friday, February 10th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were Chemours' earnings last quarter? The Chemours Company (NYSE:CC) issued its quarterly earnings results on Thursday, November, 4th. The specialty chemicals company reported $1.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.99 by $0.28. The specialty chemicals company earned $1.68 billion during the quarter, compared to analyst estimates of $1.58 billion. Chemours had a net margin of 12.91% and a trailing twelve-month return on equity of 73.45%. Chemours's quarterly revenue was up 36.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.47 EPS. How often does Chemours pay dividends? What is the dividend yield for Chemours? Chemours declared a quarterly dividend on Tuesday, October 25th. Stockholders of record on Tuesday, November 15th will be paid a dividend of $0.25 per share on Thursday, December 15th. This represents a $1.00 annualized dividend and a dividend yield of 2.79%. The ex-dividend date of this dividend is Monday, November 14th. Read our dividend analysis for CC. Is Chemours a good dividend stock? Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 2.75%. The dividend payout ratio is 17.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CC will have a dividend payout ratio of 23.04% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CC. What is Mark Vergnano's approval rating as Chemours' CEO? 106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees. What other stocks do shareholders of Chemours own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET). What is Chemours' stock symbol? Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC." Who are Chemours' major shareholders? Chemours' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.85%), Folger Nolan Fleming Douglas Capital Management Inc. (0.48%), Private Management Group Inc. (0.34%), Hancock Whitney Corp (0.19%), New York State Teachers Retirement System (0.15%) and Wedge Capital Management L L P NC (0.14%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, E Bryan Snell, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Richard H Brown and Sameer Ralhan. View institutional ownership trends. How do I buy shares of Chemours? Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Chemours' stock price today? One share of CC stock can currently be purchased for approximately $35.89. How much money does Chemours make? Chemours (NYSE:CC) has a market capitalization of $5.42 billion and generates $6.35 billion in revenue each year. The specialty chemicals company earns $608 million in net income (profit) each year or $5.61 on an earnings per share basis. How many employees does Chemours have? The company employs 6,400 workers across the globe. How can I contact Chemours? Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com. This page (NYSE:CC) was last updated on 2/4/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.